Department of Clinical Radiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110, Ioannina, Greece.
Department of Newer Imaging Methods of Tomography, General Anti-Cancer Hospital Agios Savvas, 11522, Athens, Greece.
Eur J Radiol. 2021 Aug;141:109777. doi: 10.1016/j.ejrad.2021.109777. Epub 2021 May 15.
The wide availability of cross-sectional imaging is responsible for the increased detection of small, usually asymptomatic renal masses. More than 50 % of renal cell carcinomas (RCCs) represent incidental findings on noninvasive imaging. Multimodality imaging, including conventional US, contrast-enhanced US (CEUS), CT and multiparametric MRI (mpMRI) is pivotal in diagnosing and characterizing a renal mass, but also provides information regarding its prognosis, therapeutic management, and follow-up. In this review, imaging data for renal masses that urologists need for accurate treatment planning will be discussed. The role of US, CEUS, CT and mpMRI in the detection and characterization of renal masses, RCC staging and follow-up of surgically treated or untreated localized RCC will be presented. The role of percutaneous image-guided ablation in the management of RCC will be also reviewed.
横断面成像的广泛应用导致了对小的、通常无症状的肾肿块的检测增加。超过 50%的肾细胞癌（RCC）是在非侵入性成像上偶然发现的。多模态成像，包括常规超声、对比增强超声（CEUS）、CT 和多参数 MRI（mpMRI），在诊断和描述肾肿块方面至关重要，但也提供了关于其预后、治疗管理和随访的信息。在这篇综述中，将讨论泌尿科医生为了准确的治疗计划所需的肾肿块的成像数据。将介绍超声、CEUS、CT 和 mpMRI 在肾肿块的检测和特征描述、RCC 分期以及手术治疗或未治疗的局限性 RCC 的随访中的作用。还将回顾经皮影像引导消融在 RCC 治疗中的作用。
